Skip to main content

Table 4 Predicted number of procedures per 100,000 women screened at age 35 years

From: Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study

Screening test

Colposcopy

Biopsy†

Treatment for precancerous lesions

Colposcopy/ treatment ratio

VIA only

6,068

1,920

791

7.7

VIA/VILI

17,881

4,640

1,036

17.3

careHPV@1.0 pg/ml

8,124

3,010

1,493

5.4

careHPV@0.5 pg/ml

8,478

3,164

1,587

5.3

  1. † Biopsy does not include diagnoses from ECC.